Profound Medical PROF EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Profound Medical’s reported figures.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's EBITDA?
- Profound Medical (PROF) reported EBITDA of -$7.92M in Q1 2026.
- How has Profound Medical's EBITDA changed year-over-year?
- Profound Medical's EBITDA increased by 28.0% year-over-year, from -$11M to -$7.92M.
- What is the long-term trend for Profound Medical's EBITDA?
- Over 2 years (2023 to 2025), Profound Medical's EBITDA has grown at a 21.2% compound annual growth rate (CAGR), from -$27.72M to -$40.69M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.